Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Santacana

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasiasCristina Mirantes, Maria Alba Dosil, Núria Eritja, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 2022
Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney functionJorge González, Elias Jatem, Jordi Roig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2011
FGFR2 alterations in endometrial carcinomaSonia Gatius, Ana Velasco, Ainara Azueta, et al.
Autophagy|January 10, 2018
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockersMireia Nàger, Marta C Sallán, Anna Visa, et al.
Cancer Research|February 14, 2019
T-Type Ca<sub>v</sub>3.1 Channels Mediate Progression and Chemotherapeutic Resistance in GlioblastomaAnna Visa, Marta C Sallán, Oscar Maiques, et al.
Virchows Archiv : an International Journal of Pathology|June 4, 2025
EPM2 AIP1 immunohistochemistry as a surrogate of promoter methylation analysis in endometrial carcinomaSonia Gatius, Marta Vaquero, Oliver Scheiber, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 27, 2008
Loss of heterozygosity in endometrial carcinomaAna Velasco, Judit Pallares, Maria Santacana, et al.
Analytical and Quantitative Cytology and Histology|September 10, 2009
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinomaJudit Pallares, Maria Santacana, Soraya Puente, et al.
Molecular Cancer Therapeutics|January 23, 2014
Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cellsNuria Eritja, Mónica Domingo, Maria Alba Dosil, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2008
Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinomaJudit Pallarés, Ana Velasco, Nuria Eritja, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasiasCristina Mirantes, Maria Alba Dosil, Núria Eritja, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 2022
Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney functionJorge González, Elias Jatem, Jordi Roig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2011
FGFR2 alterations in endometrial carcinomaSonia Gatius, Ana Velasco, Ainara Azueta, et al.
Autophagy|January 10, 2018
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockersMireia Nàger, Marta C Sallán, Anna Visa, et al.
Cancer Research|February 14, 2019
T-Type Ca<sub>v</sub>3.1 Channels Mediate Progression and Chemotherapeutic Resistance in GlioblastomaAnna Visa, Marta C Sallán, Oscar Maiques, et al.
Virchows Archiv : an International Journal of Pathology|June 4, 2025
EPM2 AIP1 immunohistochemistry as a surrogate of promoter methylation analysis in endometrial carcinomaSonia Gatius, Marta Vaquero, Oliver Scheiber, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 27, 2008
Loss of heterozygosity in endometrial carcinomaAna Velasco, Judit Pallares, Maria Santacana, et al.
Analytical and Quantitative Cytology and Histology|September 10, 2009
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinomaJudit Pallares, Maria Santacana, Soraya Puente, et al.
Molecular Cancer Therapeutics|January 23, 2014
Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cellsNuria Eritja, Mónica Domingo, Maria Alba Dosil, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2008
Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinomaJudit Pallarés, Ana Velasco, Nuria Eritja, et al.
Pageof 8